These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 37245030

  • 1. Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).
    Freedman SB, Schnadower D, Estes M, Casper TC, Goldstein SL, Grisaru S, Pavia AT, Wilfond BS, Metheney M, Kimball K, Tarr PI, Hyperhydration to Improve Kidney Outcomes in children with Shiga Toxin-producing E. Coli infection (HIKO-STEC) Study Team .
    Trials; 2023 May 27; 24(1):359. PubMed ID: 37245030
    [Abstract] [Full Text] [Related]

  • 2. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
    Bai X, Ylinen E, Zhang J, Salmenlinna S, Halkilahti J, Saxen H, Narayanan A, Jahnukainen T, Matussek A.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0066022. PubMed ID: 35730965
    [Abstract] [Full Text] [Related]

  • 3. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G, Vignati C, Masia C, Capone V, Colombo R, Tel F, Daprai L, Testa S, Dodaro A, Paglialonga F, Luini M, Brigotti M, Picicco D, Baldioli C, Pagani F, Ceruti R, Tommasi P, Possenti I, Cresseri D, Consonni D, Montini G, Arghittu M, ItalKid-HUS Network.
    J Pediatr; 2021 Oct 31; 237():34-40.e1. PubMed ID: 34197890
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic Syndrome.
    Liu Y, Thaker H, Wang C, Xu Z, Dong M.
    Toxins (Basel); 2022 Dec 23; 15(1):. PubMed ID: 36668830
    [Abstract] [Full Text] [Related]

  • 5. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI.
    Pediatrics; 2005 Jun 23; 115(6):e673-80. PubMed ID: 15930195
    [Abstract] [Full Text] [Related]

  • 6. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
    Khalid M, Andreoli S.
    Pediatr Nephrol; 2019 Dec 23; 34(12):2495-2507. PubMed ID: 30382336
    [Abstract] [Full Text] [Related]

  • 7. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M, Mariani-Kurkdjian P, Gouali M, de Valk H, King LA, Le Hello S, Bonacorsi S, Loirat C.
    Med Mal Infect; 2018 May 23; 48(3):167-174. PubMed ID: 29054297
    [Abstract] [Full Text] [Related]

  • 8. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L, Gaiani F, Vincenzi F, Kayali S, Di Mario F, Leandro G, De' Angelis GL, Ruberto C.
    Acta Biomed; 2018 Dec 17; 89(9-S):153-157. PubMed ID: 30561409
    [Abstract] [Full Text] [Related]

  • 9. Volume expansion mitigates Shiga toxin-producing E. coli-hemolytic uremic syndrome in children.
    Böckenhauer J, Schild R, Kemper MJ, Henne T, Stein MV, Oh J, Loos S.
    Pediatr Nephrol; 2024 Jun 17; 39(6):1901-1907. PubMed ID: 38240870
    [Abstract] [Full Text] [Related]

  • 10. Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.
    Peco-Antić A.
    Srp Arh Celok Lek; 2016 Jun 17; 144(11-12):664-9. PubMed ID: 29659236
    [Abstract] [Full Text] [Related]

  • 11. Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome.
    Imdad A, Mackoff SP, Urciuoli DM, Syed T, Tanner-Smith EE, Huang D, Gomez-Duarte OG.
    Cochrane Database Syst Rev; 2021 Jul 05; 7(7):CD012997. PubMed ID: 34219224
    [Abstract] [Full Text] [Related]

  • 12. Prodromal Phase of Hemolytic Uremic Syndrome Related to Shiga Toxin-Producing Escherichia coli: The Wasted Time.
    Balestracci A, Meni Battaglia L, Toledo I, Martin SM, Alvarado C.
    Pediatr Emerg Care; 2021 Oct 01; 37(10):e625-e630. PubMed ID: 31290797
    [Abstract] [Full Text] [Related]

  • 13. Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.
    McKee RS, Schnadower D, Tarr PI, Xie J, Finkelstein Y, Desai N, Lane RD, Bergmann KR, Kaplan RL, Hariharan S, Cruz AT, Cohen DM, Dixon A, Ramgopal S, Rominger A, Powell EC, Kilgar J, Michelson KA, Beer D, Bitzan M, Pruitt CM, Yen K, Meckler GD, Plint AC, Bradin S, Abramo TJ, Gouin S, Kam AJ, Schuh A, Balamuth F, Hunley TE, Kanegaye JT, Jones NE, Avva U, Porter R, Fein DM, Louie JP, Freedman SB, Pediatric Emergency Medicine Collaborative Research Committee and Pediatric Emergency Research Canada.
    Clin Infect Dis; 2020 Apr 10; 70(8):1643-1651. PubMed ID: 31125419
    [Abstract] [Full Text] [Related]

  • 14. Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage.
    Luna M, Kamariski M, Principi I, Bocanegra V, Vallés PG.
    Pediatr Nephrol; 2021 Jun 10; 36(6):1499-1509. PubMed ID: 33205220
    [Abstract] [Full Text] [Related]

  • 15. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL, Contrini MM, Glatstein E, Ayala SG, Santoro R, Ezcurra G, Teplitz E, Matsumoto Y, Sato H, Sakai K, Katsuura Y, Hoshide S, Morita T, Harning R, Brookman S.
    Pediatr Infect Dis J; 2012 Jan 10; 31(1):20-4. PubMed ID: 21829137
    [Abstract] [Full Text] [Related]

  • 16. Hemoglobinuria for the early identification of STEC-HUS in high-risk children: data from the ItalKid-HUS Network.
    Capone V, Mancuso MC, Tamburini G, Montini G, Ardissino G.
    Eur J Pediatr; 2021 Sep 10; 180(9):2791-2795. PubMed ID: 33759020
    [Abstract] [Full Text] [Related]

  • 17. Hemolytic-Uremic Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999.
    McCarthy TA, Barrett NL, Hadler JL, Salsbury B, Howard RT, Dingman DW, Brinkman CD, Bibb WF, Cartter ML.
    Pediatrics; 2001 Oct 10; 108(4):E59. PubMed ID: 11581467
    [Abstract] [Full Text] [Related]

  • 18. Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study.
    Myojin S, Pak K, Sako M, Kobayashi T, Takahashi T, Sunagawa T, Tsuboi N, Ishikura K, Kubota M, Kubota M, Igarashi T, Morioka I, Miyairi I.
    PLoS One; 2022 Oct 10; 17(2):e0263349. PubMed ID: 35120154
    [Abstract] [Full Text] [Related]

  • 19. Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy.
    Loconsole D, Giordano M, Laforgia N, Torres D, Santangelo L, Carbone V, Parisi A, Quarto M, Scavia G, Chironna M, Bloody Diarrhea Apulia Working Group.
    Eur J Clin Microbiol Infect Dis; 2020 Mar 10; 39(3):539-547. PubMed ID: 31776873
    [Abstract] [Full Text] [Related]

  • 20. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A.
    BMC Infect Dis; 2016 Jun 13; 16():285. PubMed ID: 27297224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.